New study aims to sharpen rejection detection in liver transplants

NCT ID NCT03193151

Recruiting now Knowledge-focused Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at liver transplant biopsy samples to better understand and predict organ rejection. Researchers will analyze gene activity in 300 biopsy samples from transplant patients to create a tool that can identify rejection types more accurately. Participants are those already receiving a biopsy as part of their standard care. The goal is to improve diagnosis, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER DYSFUNCTION

Contacts and locations

Locations

Baylor University Medical Center, Annette C. and Harold C. Simmons Transplant Institute
COMPLETED

Dallas, Texas, 75246, United States
Centenary Institute of Cancer Medicine & Cell Biology, Royal Prince Alfred Hospital
COMPLETED

Camperdown, NSW 2050, Australia
Dep. of Nephrology, Transplantation & Internal Med., Samodzielny Publiczny Szpital Kliniczny im. A. Mieleckiego
COMPLETED

Katowice, 40-027, Poland
Division of Transplant Surgery, University of Washington
COMPLETED

Seattle, Washington, 98195, United States
Henry Ford Transplant Institute
RECRUITING

Detroit, Michigan, 48202, United States
Independent Public Composite Regional Hospital
COMPLETED

Szczecin, 71-455, Poland
Institute for Liver Science, King's College London
COMPLETED

London, SE5 9NU, United Kingdom
Northwestern Memorial Hospital
COMPLETED

Chicago, Illinois, 60611, United States
Transplant Surgery, VCU Medical Center
COMPLETED

Richmond, Virginia, 23298, United States
University of Alberta, Laboratory Medicine and Pathology
COMPLETED

Edmonton, Alberta, T6G 2R7, Canada
University of California San Francisco, Transplant Research Unit
COMPLETED

San Francisco, California, 94143, United States
University of Maryland School of Medicine
COMPLETED

Baltimore, Maryland, 21201, United States
Vanderbilt University Medical Center, Vanderbilt Transplant Center
WITHDRAWN

Nashville, Tennessee, 37232, United States
Warsaw Medical University, Independent Public Clinical Hospital
COMPLETED

Warsaw, 02-097, Poland
Warsaw Medical University, Jesus the Child Clinical Hospital
COMPLETED

Warsaw, 02-005, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.